MMJ Recs

NOVEMBER 2, 2023

The real stories around medical marijuana (MMJ) are those of the patients who have experienced life-changing benefits from cannabis therapy. In this article, we’ll explore MMJ patient success stories in West Virginia and how cannabis therapy is positively impacting patients’ lives.

Patients 98

Patients Chronic Pain Therapy Treatment 98

MMJ Recs

NOVEMBER 17, 2023

It has improved the quality of life for those dealing with chronic pain, nausea, seizures, and other medical conditions. Promoting Research and Innovation The medical marijuana industry promotes research and innovation in the field of cannabis-based therapies.

Chronic Pain 98

Chronic Pain Therapy Research and Development Treatment 98

Cannabis Law Report

JUNE 23, 2021

The analysis of patient-reported outcome measures following treatment with cannabis-based medicinal products (CBMPs) in a study covering patients with all conditions found statistically significant improvements in anxiety, sleep , and general quality of life at one, three, and six months following treatment, compared to baseline assessment.

Cannabinoids 59

Cannabinoids Data Chronic Pain Sleep 59

Cannabis Law Report

APRIL 12, 2019

I use medical cannabis for my skin, pain, mood, fatigue, appetite and, most importantly, sleep. I am also prescribed pharmacological and non-pharmacological therapies and try to keep a base of exercise and good nutrition. Patient advocacy is alive and well in Canada. This is what it means to be Canadian to me.

Access 45

Access Patients Marijuana Medicine 45

The Cannigma

JANUARY 19, 2022

Today on the show we welcome Nikki Lawley, a Traumatic Brain Injury Survivor, and founder of NIKKI and the Plant, an advocacy group for medical marijuana use, with a special focus on helping women who have suffered a TBI. I mean, asking questions was like, how can I function, how can I sleep, how can I not be in pain.

Patients 83

Patients Compliance Compliance Cannabis 83

Cannabis Law Report

NOVEMBER 24, 2021

Media representations can offer insights into the nature of the discourse about new medical products and therapies and how ideas and understandings about social phenomena become constructed. Pain and chronic pain were the most common conditions mentioned over the time period and were referred to in 62% of all articles.

Research and Development 52

Research and Development Medicine Access Media 52

The Cannigma

DECEMBER 12, 2022

The results are so compelling that the FDA has categorized magic mushrooms as a “breakthrough therapy” for depression, and is committed to fast tracking its approval. Stage three lasts up to 72 hours after ingestion, and is characterized by mild stimulation, heightened awareness and disrupted sleep. 19 20 21 22 23.

History 119

History Microdosing Research and Development Clinical Trials 119